Cx Institutional Vertex Pharmaceuticals Inc Transaction History

Cx Institutional

$2.5 Billion
Q4 2024

A detailed history of Cx Institutional transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cx Institutional holds 1,639 shares of VRTX stock, worth $720,537. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,639

Previous 1,628 0.68%

Holding current value

$720,537

Previous $757,000 12.81%

% of portfolio

0.03%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$396.64 - $516.74 $4,363 - $5,684	11 Added 0.68%	1,639 $660,000
Q3 2024 Oct 11, 2024	BUY	$460.0 - $505.78 $1,380 - $1,517	3 Added 0.18%	1,628 $757,000
Q2 2024 Jul 11, 2024	SELL	$392.81 - $485.53 $7,070 - $8,739	-18 Reduced 1.1%	1,625 $761,000
Q1 2024 Apr 15, 2024	SELL	$407.69 - $446.08 $15,084 - $16,504	-37 Reduced 2.2%	1,643 $686,000
Q4 2023 Jan 12, 2024	SELL	$343.0 - $410.68 $7,203 - $8,624	-21 Reduced 1.23%	1,680 $683,000
Q3 2023 Oct 17, 2023	SELL	$338.18 - $362.46 $7,778 - $8,336	-23 Reduced 1.33%	1,701 $591,000
Q2 2023 Jul 26, 2023	BUY	$314.42 - $351.91 $943 - $1,055	3 Added 0.17%	1,724 $606,000
Q1 2023 May 04, 2023	BUY	$283.23 - $323.1 $120,372 - $137,317	425 Added 32.79%	1,721 $542,000
Q4 2022 Feb 03, 2023	BUY	$285.76 - $321.48 $27,147 - $30,540	95 Added 7.91%	1,296 $374,000
Q3 2022 Nov 04, 2022	BUY	$273.83 - $305.53 $131,438 - $146,654	480 Added 66.57%	1,201 $348,000
Q2 2022 Aug 02, 2022	BUY	$234.96 - $292.55 $169,406 - $210,928	721 New	721 $204,000
Q4 2021 Jan 18, 2022	SELL	$177.01 - $223.45 $8,319 - $10,502	-47 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$181.39 - $202.99 $52,058 - $58,258	-287 Reduced 85.93%	47 $9,000
Q2 2021 Aug 04, 2021	SELL	$187.49 - $221.1 $11,999 - $14,150	-64 Reduced 16.08%	334 $67,000
Q1 2021 Apr 15, 2021	BUY	$207.02 - $241.31 $17,803 - $20,752	86 Added 27.56%	398 $86,000
Q4 2020 Jan 12, 2021	BUY	$207.01 - $276.09 $31,879 - $42,517	154 Added 97.47%	312 $74,000
Q3 2020 Oct 13, 2020	BUY	$255.65 - $303.1 $7,158 - $8,486	28 Added 21.54%	158 $43,000
Q2 2020 Aug 06, 2020	BUY	$225.48 - $295.8 $4,960 - $6,507	22 Added 20.37%	130 $38,000
Q1 2020 Apr 29, 2020	BUY	$199.77 - $247.81 $10,987 - $13,629	55 Added 103.77%	108 $26,000
Q4 2019 Jan 21, 2020	BUY	$166.71 - $223.91 $666 - $895	4 Added 8.16%	53 $12,000
Q3 2019 Oct 10, 2019	BUY	$166.23 - $187.09 $8,145 - $9,167	49 New	49 $8,000
Q2 2019 Jul 17, 2019	SELL	$164.61 - $190.37 $4,115 - $4,759	-25 Closed	0 $0
Q1 2019 Apr 03, 2019	BUY	$163.73 - $194.7 $4,093 - $4,867	25 New	25 $5,000

Others Institutions Holding VRTX

# of Institutions

1,708

Shares Held

220M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $113B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.

Account

Cx Institutional Vertex Pharmaceuticals Inc Transaction History